GlobeNewswire Inc.··NaProtara Therapeutics to Present TARA-002 Data at Major Medical Conferences
Protara Therapeutics will present TARA-002 Phase 2 interim data at ASCO GU Symposium, showcasing results for BCG-unresponsive bladder cancer treatment.
TARAinvestor conferencebladder cancer